Ausgabe 1/2022
Inhalt (5 Artikel)
Molecular subtyping of ependymoma and prognostic impact of Ki-67
Ka Young Lim, Kwanghoon Lee, Yumi Shim, Jin Woo Park, Hyunhee Kim, Jeongwan Kang, Jae Kyung Won, Seung-Ki Kim, Ji Hoon Phi, Chul-Kee Park, Chun-Kee Chung, Hongseok Yun, Sung-Hye Park
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas
Tomohide Nishikawa, Reiko Watanabe, Yotaro Kitano, Akane Yamamichi, Kazuya Motomura, Fumiharu Ohka, Kosuke Aoki, Masaki Hirano, Akira Kato, Junya Yamaguchi, Sachi Maeda, Yuji Kibe, Ryuta Saito, Toshihiko Wakabayashi, Yukinari Kato, Shuta Sato, Tomoyoshi Ogino, Atsushi Natsume, Ichiro Ito
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
Shino Magaki, Radha Satyadev, Zesheng Chen, Kathryn S. Yung, Harry V. Vinters, Marsha C. Kinney, Jonathan W. Said
Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature
Shefali Chopra, Nolan Maloney, Wei Lien Wang
Correction to: Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature
Shefali Chopra, Nolan Maloney, Wei Lien Wang